PT-141

PT-141 Canada

PT-141, also known as bremelanotide, is a synthetic cyclic peptide studied for its interaction with the melanocortin receptor system. It is related to alpha-melanocyte-stimulating hormone. The peptide has attracted attention in research involving central nervous system signalling, neuroendocrine function, and sexual behaviour.

Research involving PT-141 has focused on several melanocortin receptor subtypes, including MC1R, MC3R, and MC4R. MC4R is expressed throughout areas of the central nervous system. This makes PT-141 particularly interesting for studies of receptor activation, neural signalling, motivation, and behavioural responses.

One of the most recognized areas of PT-141 research involves libido, sexual desire, and arousal pathways in both males and females. Studies have examined how melanocortin signalling may influence sexual motivation, arousal responses, and behaviour through central nervous system pathways.

Unlike compounds studied primarily for peripheral blood-flow pathways, PT-141 research focuses on centrally mediated signalling. Researchers have examined hypothalamic activity and communication between the nervous and endocrine systems. This distinct mechanism makes PT-141 especially interesting for research into the neurobiology of sexual function.

PT-141 also provides a useful model for receptor pharmacology. Researchers may use it to examine cyclic peptide structure, receptor affinity, and melanocortin signalling. These studies help explore biological responses across different experimental systems.

For researchers seeking PT-141 peptide in Canada, it represents a versatile compound for melanocortin, libido, arousal, behavioural, and neuroendocrine research.

Exploring related areas of peptide research? Browse our research peptide collection for additional compounds with distinct structures and research profiles.

For laboratory and research purposes only. Not intended for human or veterinary use, diagnosis, treatment, or consumption.